Ke Wang

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Inflammatory Response

Postmenopausal Women

Top Venues

Drug design, development and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Ke Wang, Yuying Kou, Xing Rong, Lingling Wei, Jingyuan Li, Hongrui Liu, Minqi Li, Hui Song
ED-71 Improves Bone Mass in Ovariectomized Rats by Inhibiting Osteoclastogenesis Through EphrinB2-EphB4-RANKL/OPG Axis. Drug design, development and therapy 18 (2024)
Ke Wang, Yuying Kou, Xing Rong, Lingling Wei, Jingyuan Li, Hongrui Liu, Minqi Li, Hui Song
ED-71 Improves Bone Mass in Ovariectomized Rats by Inhibiting Osteoclastogenesis Through EphrinB2-EphB4-RANKL/OPG Axis. Drug design, development and therapy 18 (2024)
Ke Wang, Yuying Kou, Xing Rong, Lingling Wei, Jingyuan Li, Hongrui Liu, Minqi Li, Hui Song
ED-71 Improves Bone Mass in Ovariectomized Rats by Inhibiting Osteoclastogenesis Through EphrinB2-EphB4-RANKL/OPG Axis. Drug design, development and therapy 18 (2024)